Cancer Therapeutics - The Challenge Is Not to Discover New Targets

The company is focused on the molecular engineering side of making therapeutic agents. It's not about discovering new targets, but how to make good use of molecules that we already know about. Employees can sit with a laptop on the beach perform everything you need to do for drug design through some combination of machine learning and biophysical simulation. How far away are we from that future? i actually don't think we're that far away.